The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies

JACC: Heart Failure

Volumn 3, Issue 10, 2015, Pages 818-828

  Teuteberg, Jeffrey J ^a   Slaughter, Mark S ^b   Rogers, Joseph G ^c   McGee, Edwin C ^d   Pagani, Francis D ^e   Gordon, Robert ^f   Rame, Eduardo ^g   Acker, Michael ^g   Kormos, Robert L ^a   Salerno, Christopher ^h   Schleeter, Thomas P ^h   Goldstein, Daniel J ⁱ   Shin, Julia ⁱ   Starling, Randall C ^j   Wozniak, Thomas ^k   Malik, Adnan S ^k   Silvestry, Scott ^l   Ewald, Gregory A ^m   Jorde, Ulrich P ⁱ   Naka, Yoshifumi ⁿ   Birks, Emma ^b   Najarian, Kevin B ^o   Hathaway, David R ^o   Aaronson, Keith D ^e   more..

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c DUKE UNIVERSITY   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h ST VINCENT HOSPITAL   (United States)

ⁱ MONTEFIORE MEDICAL CENTER   (United States)

^j LERNER RESEARCH INSTITUTE   (United States)

^k INDIANA UNIVERSITY   (United States)

^l FLORIDA HOSPITAL   (United States)

^m WASHINGTON UNIVERSITY   (United States)

ⁿ Och Spine at New York Presbyterian Hospitals   (United States)

^o HEARTWARE INC   (United States)

more..

Author keywords

Cerebrovascular event; CVA; Heart failure; Stroke; VAD; Ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ARTICLE; ATRIAL FIBRILLATION; BLOOD PRESSURE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAUCASIAN; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; ADVERSE EFFECTS; AGED; CAUSE OF DEATH; CLINICAL TRIAL; FOLLOW UP; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; BRAIN ISCHEMIA; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL RATE; TREATMENT OUTCOME; WAITING LISTS;

EID: 84941188506     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.05.011     Document Type: Article

References (31)

1. Stewart G.C., Givertz M.M. Mechanical circulatory support for advanced heart failure. Circulation 2012, 125:1304-1315.
2. Park S.J., Kushwaha S.S., McGregor C.G. State-of-the-art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapy. Clin Pharmacol Ther 2012, 91:94-100.
3. Feldman D., Pamboukian S.V., Teuteberg J.J., et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 2013, 32:157-187.
4. Topkara V.K., Kondareddy S., Malik F., et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 2010, 90:1270-1277.
5. Toda K., Yonemoto Y., Fujita T., et al. Risk analysis of bloodstream infection during long-term left ventricular assist device support. Ann Thorac Surg 2012, 94:1387-1393.
6. Kato T.S., Schulze P.C., Yang J., et al. Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. J Heart Lung Transplant 2012, 31:1-8.
7. Gordon R.J., Weinberg A.D., Pagani F.D., et al. A prospective, multicenter study of ventricular assist device infections. Circulation 2013, 127:691-702.
8. Goldstein D.J., Naftel D., Holman W., et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant 2012, 31:1151-1157.
9. Eckman P.M., John R. Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation 2012, 125:3038-3047.
10. Aggarwal A., Pant R., Kumar S., et al. Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg 2012, 93:1534-1540.
11. Najjar S.S., Slaughter M.S., Pagani F.D., et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 2014, 33:23-34.
12. Starling R.C., Moazami N., Silvestry S.C., et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014, 370:33-40.
13. Kirklin J.K., Naftel D.C., Kormos R.L., et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant 2014, 33:12-22.
14. Kirklin J.K., Naftel D.C., Kormos R.L., et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transpl 2013, 32:141-156.
15. Strueber M., Larbalestier R., Jansz P., et al. Results of a postmarket registry to evaluate the HeartWare® left ventricular assist system (ReVOLVE). J Heart Lung Transplant 2014, 33:486-491.
16. Strueber M., O'Driscoll G., Jansz P., et al. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 2011, 57:1375-1382.
17. Pagani F.D., Miller L.W., Russell S.D., et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009, 54:312-321.
18. Slaughter M.S., Pagani F.D., McGee E.C., et al. Use of the HeartWare® ventricular assist system for bridge to transplant: combined results of the ADVANCE and CAP Trial. J Heart Lung Transplant 2013, 32:675-683.
19. Starling R.C., Naka Y., Boyle A.J., et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011, 57:1890-1898.
20. Aggarwal A., Gupta A., Kumar S., et al. Are blood stream infections associated with an increased risk of hemorrhagic stroke in patients with a left ventricular assist device?. ASAIO J 2012, 58:509-513.
21. Boyle A.J., Russell S.D., Teuteberg J.J., et al. Low thromboembolism and pump thrombosis with the Heartmate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 2009, 28:881-887.
22. Aaronson K.D., Slaughter M.S., Miller L.W., et al. Use of an intrapericardial, continuous flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012, 125:3191-3200.
23. Farrell B., Godwin J., Richards S., Warlow C. The United Kingdom Transient Ischaemic Attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991, 54:1044-1054.
24. Rosendaal F.R., Cannegieter S.C., van der Meer F.J., Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993, 69:236-239.
25. Kim H.J., Song J.M., Kwon S.U., et al. Right-left propensity and lesion patterns between cardiogenic and aortogenic cerebral embolisms. Stroke 2011, 42:2323-2325.
26. Okada Y., Yamaguchi T., Minematsu K., et al. Hemorrhagic transformation in cerebral embolism. Stroke 1989, 20:598-603.
27. Kar B., Delgado R.M., Frazier O.H., et al. The effect of LVAD aortic outflow-graft placement on hemodynamics and flow: implantation technique and computer flow modeling. Tex Heart Inst J 2005, 32:294-298.
28. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983-988.
29. Frazier O.H., Delgado R.M., Kar B., Patel V., Gregoric I.D., Myers T.J. First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report. Tex Heart Inst J 2004, 31:157-159.
30. Lanier G.M., Orlanes K., Hayashi Y., et al. Validity and reliability of a novel slow cuff-deflation system for noninvasive blood pressure monitoring in patients with continuous-flow left ventricular assist device. Circ Heart Fail 2013, 6:1005-1012.
31. Lampert B.C., Eckert C., Weaver S., et al. Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events. Ann Thoracic Surg 2014, 97:139-146.